140 related articles for article (PubMed ID: 25364428)
21. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer].
Zhang FR; He XB; Yang YH; Xie W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):31-4. PubMed ID: 12579496
[TBL] [Abstract][Full Text] [Related]
22. Relaxed imprinting of IGF2 in peripheral blood cells of patients with a history of prostate cancer.
Belharazem D; Kirchner M; Geissler F; Bugert P; Spahn M; Kneitz B; Riedmiller H; Sauer C; Küffer S; Trojan L; Bolenz C; Michel MS; Marx A; Ströbel P
Endocr Connect; 2012 Nov; 1(2):87-94. PubMed ID: 23781309
[TBL] [Abstract][Full Text] [Related]
23. Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications.
Belharazem D; Magdeburg J; Berton AK; Beissbarth L; Sauer C; Sticht C; Marx A; Hofheinz R; Post S; Kienle P; Ströbel P
J Gastroenterol; 2016 Oct; 51(10):971-84. PubMed ID: 26984550
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive methylation analysis of imprinting-associated differentially methylated regions in colorectal cancer.
Hidaka H; Higashimoto K; Aoki S; Mishima H; Hayashida C; Maeda T; Koga Y; Yatsuki H; Joh K; Noshiro H; Iwakiri R; Kawaguchi A; Yoshiura KI; Fujimoto K; Soejima H
Clin Epigenetics; 2018 Dec; 10(1):150. PubMed ID: 30509319
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2.
Sasaki J; Konishi F; Kawamura YJ; Kai T; Takata O; Tsukamoto T
Int J Cancer; 2006 Jul; 119(1):80-3. PubMed ID: 16432831
[TBL] [Abstract][Full Text] [Related]
26. Loss of imprinting and loss of heterozygosity on 11p15.5 in head and neck squamous cell carcinomas.
Rainho CA; Kowalski LP; Rogatto SR
Head Neck; 2001 Oct; 23(10):851-9. PubMed ID: 11592232
[TBL] [Abstract][Full Text] [Related]
27. [Study on the expression and genomic imprinting status of insulin-like growth factor 2 gene in hepatocellular carcinoma].
Li H; Zhang N
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):347-9. PubMed ID: 15225429
[TBL] [Abstract][Full Text] [Related]
28. Loss of imprinting of IGF2 in Ewing's sarcoma.
Zhan S; Shapiro DN; Helman LJ
Oncogene; 1995 Dec; 11(12):2503-7. PubMed ID: 8545106
[TBL] [Abstract][Full Text] [Related]
29. Loss of imprinting and promoter usage of the IGF2 in laryngeal squamous cell carcinoma.
Grbesa I; Ivkic M; Pegan B; Gall-Troselj K
Cancer Lett; 2006 Jul; 238(2):224-9. PubMed ID: 16111804
[TBL] [Abstract][Full Text] [Related]
30. IGF2 expression in blood is not associated with its imprinting status in healthy pregnant Chinese women.
Ru-Fei G; Xue-Qing L; Ying-Xiong W; Xue-Mei C; Yu-Bin D; Jun-Lin H
Biol Res; 2012; 45(4):351-6. PubMed ID: 23558990
[TBL] [Abstract][Full Text] [Related]
31. Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer.
Takano Y; Shiota G; Kawasaki H
Oncology; 2000 Sep; 59(3):210-6. PubMed ID: 11053988
[TBL] [Abstract][Full Text] [Related]
32. Frequent loss of imprinting of IGF2 and MEST in lung adenocarcinoma.
Kohda M; Hoshiya H; Katoh M; Tanaka I; Masuda R; Takemura T; Fujiwara M; Oshimura M
Mol Carcinog; 2001 Aug; 31(4):184-91. PubMed ID: 11536368
[TBL] [Abstract][Full Text] [Related]
33. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
Vu TH; Hoffman A
J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
[TBL] [Abstract][Full Text] [Related]
34. Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma.
Nonomura N; Nishimura K; Miki T; Kanno N; Kojima Y; Yokoyama M; Okuyama A
Cancer Res; 1997 Jul; 57(13):2575-7. PubMed ID: 9205056
[TBL] [Abstract][Full Text] [Related]
35. Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition.
Cruz-Correa M; Cui H; Giardiello FM; Powe NR; Hylind L; Robinson A; Hutcheon DF; Kafonek DR; Brandenburg S; Wu Y; He X; Feinberg AP
Gastroenterology; 2004 Apr; 126(4):964-70. PubMed ID: 15057734
[TBL] [Abstract][Full Text] [Related]
36. Alterations in Promoter Usage and Expression Levels of Insulin-like Growth Factor-II and H19 Genes in Cervical and Endometrial Cancer.
Lee C; Kim SJ; Na JY; Park CS; Lee SY; Kim IH; Oh YK
Cancer Res Treat; 2003 Aug; 35(4):314-22. PubMed ID: 26680953
[TBL] [Abstract][Full Text] [Related]
37. Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II.
Kim SJ; Park SE; Lee C; Lee SY; Jo JH; Kim JM; Oh YK
Biochim Biophys Acta; 2002 Apr; 1586(3):307-15. PubMed ID: 11997082
[TBL] [Abstract][Full Text] [Related]
38. Imprinting, expression, and localisation of DLK1 in Wilms tumours.
Fukuzawa R; Heathcott RW; Morison IM; Reeve AE
J Clin Pathol; 2005 Feb; 58(2):145-50. PubMed ID: 15677533
[TBL] [Abstract][Full Text] [Related]
39. Loss of imprinting of IGF2 in fibroadenomas and phyllodes tumors of the breast.
Mishima C; Kagara N; Tanei T; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Oncol Rep; 2016 Mar; 35(3):1511-8. PubMed ID: 26676988
[TBL] [Abstract][Full Text] [Related]
40. Loss of imprinting in hepatoblastoma.
Rainier S; Dobry CJ; Feinberg AP
Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
